CAS: 274-76-0; Imidazo[1,2-A]Pyridine

该化合物是一种环环状有机化合物,其特点是有包括非丁二烯和虫的引信系统.该化合物通常展示成一个板状结构,有助于其芳香性的潜力.它以其多种生物活动著称,使其对药用化学和药物开发感兴趣.伊米达佐(1,2,a)衍生物可以在协调化学中起到皮片类有机化合物的作用,并经常被探究其药理特性,包括抗微生物和抗癌活动.该化合物一般在有机溶剂中溶解,其再活性可能受到替代体在芳虫圈上的存在的影响.此外,虫素(1,2,a)可参与各种化学反应,例如电药替代和核糖添加,因为其结构中存在氮原子.其独特的特性和再活性使其在学术和工业环境中的新化合物合成中成为有价值的合成体.

结构式图片

相似化合物

874-39-5 1260903-17-0 808744-34-5

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号504-29-0 2-氨基吡啶 | CAS号107-20-0 一氯乙醛 | CAS号6200-60-8 咪唑[1,2-A]吡啶-3-甲酸 | CAS号1072-98-6 2-氨基-5-氯吡啶 | CAS号1526-73-4 1,4-Naphthalene... | CAS号117-80-6 2,3-二氯-1,4-萘醌 | CAS号19798-80-2 2-氨基-4-氯吡啶 | CAS号109-09-1 2-氯吡啶 | CAS号2032-35-1 2-溴-1,1-二乙氧基乙烷 | CAS号6602-54-6 2-氯烟腈 | CAS号4926-45-8 3-硝基咪唑并[1,2-a]吡啶 | CAS号4926-47-0 3-溴咪唑[1,2-A]嘧啶 | CAS号307503-19-1 3-碘咪唑并[1,2-a]吡啶 | CAS号219296-24-9 3-(氯二氟乙酰基)咪唑并[1... | CAS号30489-43-1 3-(羟甲基)咪唑并[1,2-a]吡啶 | CAS号2717-95-5 3-[(二甲胺基)甲基]咪唑(... | CAS号29096-64-8 咪唑[1,2-a]吡啶-3-丙酮 | CAS号663946-08-5 3-(4-氯苯基)咪唑并[1,... | CAS号6188-43-8 咪唑并[1,2-a]吡啶-3-甲醛 | CAS号15562-25-1 Imidazo[1,2-a]p...

合成工艺路线路线简述

    3-溴咪唑[1,2-A]嘧啶置于sodium Tetrahydroborate,四甲基乙二胺,Palladium Diacetate,三苯基膦体系中,用 四氢呋喃 用作溶剂,化学反应 2.0H,以83%的收率获得咪唑并[1,2-A]吡啶
    参考文献:Nabh4-Tmeda And A Palladium Catalyst As Efficient Regio-And Chemoselective System For The Hydrodehalogenation Of Halogenated Heterocycles
    标题:Nabh4-Tmeda And A Palladium Catalyst As Efficient Regio-And Chemoselective System For The Hydrodehalogenation Of Halogenated Heterocycles
    摘要:
    Doi:10.1016/j.Molcata.2014.06.012

    海关参考信息

    专利信息


    专利号:WO-2024062080-A1
    优先权日:2022-09-21
    标题:Improved synthesis of psilocybin derivatives
    发明人:HAMMES CHRISTIAN; STÖCKLI STEFAN
    权利人:CARBOGEN AMCIS AG; AAMANYA AG
    摘要:The present invention relates to an improved synthesis of psilocybin and alkyl- derivatives of psilocybin such as ethocybin (4-phosphoryloxy-N,N-diethyltryptamine, also known as phosphoryloxy-DET, PO-DET or CEY-39) and furthermore, relates to intermediates useful in the synthesis of these compounds.

    专利号:US-2008125587-A1
    优先权日:2006-05-25
    标 题 :Synthesis of triazole compounds that modulate HSP90 activity
    发明人:CHIMMANAMADA DINESH U; LEE CHI-WAN; JAMES DAVID; ZHANG SHIJIE; YING WEIWEN; CHAE JUNGHYUN; PRZEWLOKA TERESA
    权利人:CHIMMANAMADA DINESH U; LEE CHI-WAN; JAMES DAVID; ZHANG SHIJIE; YING WEIWEN; CHAE JUNGHYUN; PRZEWLOKA TERESA
    摘要:The present invention provides novel methods of preparing triazole compounds which inhibit the activity of Hsp90. One embodiment of the invention is directed to methods for preparing a triazole compound represented by the following Structural Formula: n n n n n n n n n n or a tautomer, a pharmaceutically acceptable salt, solvate, or clathrate, or a prodrug thereof, comprising the steps of: a) reacting an amide represented by the following Structural Formula: n n n n n n n n n n with a thionation reagent to form a thioamide; b) reacting the thioamide of step a) with hydrazine to form a hydrazonamide; c) reacting the hydrazonamide of step b) with a carbonylation or a thiocarbonylation reagent. n In one embodiment, the present invention is a method of synthesis of a compound of formula (IA) n n n n n n n n n n or a tautomer, a pharmaceutically acceptable salt, solvate, or clathrate, or a prodrug thereof, comprising reacting a compound of formula (IIA) n n n n n n n n n n with an oxidizing agent, thereby producing a compound of formula (IA). n The present invention is also directed to a method of preparing a compound or a tautomer thereof represented by the following Structural Formula: n n n n n n n n n n or a tautomer, a pharmaceutically acceptable salt, solvate, or clathrate, or a prodrug thereof. The method comprises the step of reacting a first starting compound represented by the following Structural Formula: n n n n n n n n n n in the presence of a mercuric salt, with a second starting compound represented by the following Structural Formula:

    专利号:US-7138526-B1
    优先权日:1999-06-15
    标 题 :Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives
    发明人:HERPIN TIMOTHY F; MORTON GEORGE C; SALVINO JOSEPH M
    权利人:AVENTIS PHARMA INC
    摘要:A method for the solid phase synthesis of N,N-disubstituted diazacycloalkylcarboxy derivatives of general formula (I) and (II) is claimed. Examples include piperazine-2-carboxamide. The method is applicable to the synthesis or large combinatorial libraries

    专利号:US-7179919-B2
    优先权日:2004-03-18
    标 题 :Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
    发明人:SONG JINHUA J; TAN ZHULIN; YEE NATHAN K; SENANAYAKE CHRIS HUGH; XU JINGHUA; GALLOU FABRICE
    权利人:BOEHRINGER INGELHEIM PHARMA
    摘要:A process for stereoselective synthesis of a compound of Formula (I) n nwherein R 1 , R 2 , R 3 , R 4 , and R 5 are as described herein.

    专利号:US-2006167025-A1
    优先权日:2004-12-22
    标 题:Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugs
    发明人:BERGER MARKUS; SCHMEES NORBERT; SCHAECKE HEIKE; BAURLE STEFAN; REHWINKEL HARTMUT; MENGEL ANNE; KROLIKIEWICZ KONRAD; GROSSBACH DANJA; VOIGTLAENDER DAVID
    权利人:BERGER MARKUS; SCHMEES NORBERT; SCHAECKE HEIKE; BAURLE STEFAN; REHWINKEL HARTMUT; MENGEL ANNE; KROLIKIEWICZ KONRAD; GROSSBACH DANJA; VOIGTLAENDER DAVID
    摘要:The invention relates to tricyclic amino alcohols of general formula (I) n nmethod for synthesis of same and use of same as anti-inflammatory agents.

    专利号:US-6127515-A
    优先权日:1997-11-18
    标 题:Functionalized resin for the synthesis of amides and peptides
    发明人:MANFRE FRANCO; VANASSE BENOIT J; LABAUDINIERE RICHARD F; MORTON GEORGE C
    权利人:AVENTIS PHARM PROD INC
    摘要:This invention is directed to a functionalized amino resin of formula ##STR1## wherein S is a solid support; R is H or alkyl; A is ##STR2## Y is OH or OCOR 1 ; and R 1 is aliphatic or aromatic which is useful for the solid phase synthesis of amides, peptides and hydroxamic acids.
    连云港科联化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.klinechem.com
    企业联系👤
    📞连云港科联化工有限公司 ⚠️参考联系方式
    联系人:李先生

    手机:86-18014602686
    传真:86-518-88103267
    邮箱:sales@klinechem.com
    通信地址: 江苏省连云港市灌云县临港产业区纬五路经七路
    邮编: 222000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省连云港市灌云县临港产业区纬五路经七路
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    常州市力仁医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.lirenchem.com
    电话:0519-85859058,13915836899👤
    📞 常州市力仁医药科技有限公司⚠️参考联系方式

    电话: 0519-85859058,13915836899
    邮件:sales@lirenchem.com
    网址: http://www.lirenchem.com
    地址:江苏省常州市天宁区东仓桥弄1号
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    江苏省常州市天宁区东仓桥弄1号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Ahmed Kamal, Et Al. Efficient Solid-Phase Synthesis Of A Library Of Imidazo[参考文献]: George M Buckley, Et Al. Irak-4 Inhibitors. Part Iii: A Series Of Imidazo[参考文献]: Hao Yan, Et Al. One-Pot Three-Component Synthesis Of 3-Nitro-2-Arylimidazo[参考文献]: Huawen Huang, Et Al. Conversion Of Pyridine To Imidazo[参考文献]: Masahiko Hayakawa, Et Al. Synthesis And Biological Evaluation Of Imidazo[1,2-A]Pyridine Derivatives As Novel Pi3 Kinase P110Alpha Inhibitors. Bioorg Med Chem. 2007 Jan 1;15(1):403-12.

    合成参考文献


    参考文献:10.1107/s1600536811017077
    摘要:Dahmani S, Kandri Rodi Y, Luis SV, Essassi el M, El Ammari L. Ethyl 8-amino-6-bromoimidazo[1,2-a]pyridine-2-carb-oxy-late. Acta Crystallogr Sect E Struct Rep Online. 2011 Jun 01;67(Pt 6):o1390.
    参考文献:10.1016/j.bmcl.2011.06.090
    摘要:Ducray R, Jones CD, Jung FH, Simpson I, Curwen J, Pass M. Novel imidazo[1,2-a]pyridine based inhibitors of the IGF-1 receptor tyrosine kinase: Optimization of the aniline. Bioorganic & Medicinal Chemistry Letters. 2011 Aug;21(16):4702–4. doi: 10.1016/j.bmcl.2011.06.090.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知